Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A universal fluorescence polarization high throughput screening assay to target the SAM-binding sites of SARS-CoV-2 and other viral methyltransferases
Subodh Kumar Samrat, Qamar Bashir, Ran Zhang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

New perspective of small-molecule antiviral drugs development for RNA viruses
Shasha Li, Huixia Li, Ruiya Lian, et al.
Virology (2024) Vol. 594, pp. 110042-110042
Closed Access | Times Cited: 5
A High-Throughput Screening Pipeline to Identify Methyltransferase and Exonuclease Inhibitors of SARS-CoV-2 NSP14
Quinlin M. Hanson, Xin Hu, Sourav Pal, et al.
Biochemistry (2025)
Closed Access
SARS-CoV-2 NSP14 MTase activity is critical for inducing canonical NF-κB activation
Marie J. Tofaute, Benjamin Weller, Carina Graß, et al.
Bioscience Reports (2023) Vol. 44, Iss. 1
Open Access | Times Cited: 7
Broad-Spectrum Small-Molecule Inhibitors Targeting the SAM-Binding Site of Flavivirus NS5 Methyltransferase
Subodh Kumar Samrat, Qamar Bashir, Yiding Huang, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 7, pp. 1319-1333
Closed Access | Times Cited: 6
Structure-Based Virtual Screening for Methyltransferase Inhibitors of SARS-CoV-2 nsp14 and nsp16
Kejue Wu, Yinfeng Guo, Tiefeng Xu, et al.
Molecules (2024) Vol. 29, Iss. 10, pp. 2312-2312
Open Access | Times Cited: 1
An ISG15-Based High-Throughput Screening Assay for Identification and Characterization of SARS-CoV-2 Inhibitors Targeting Papain-like Protease
Subodh Kumar Samrat, Prashant Kumar, Yuchen Liu, et al.
Viruses (2024) Vol. 16, Iss. 8, pp. 1239-1239
Open Access | Times Cited: 1
Coronavirus 2′-O-methyltransferase: A promising therapeutic target
Craig Schindewolf, Vineet D. Menachery
Virus Research (2023) Vol. 336, pp. 199211-199211
Open Access | Times Cited: 4
Lessons learnt from broad-spectrum coronavirus antiviral drug discovery
Andrew A. Bolinger, Jun Li, Xuping Xie, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1023-1041
Closed Access
Development of a luminescence-based method for measuring West Nile Virus MTase activity and its application to screen for antivirals
Alejandra Álvarez-Mínguez, Natalia del Río, Ana Belén-Blázquez, et al.
Current Research in Microbial Sciences (2024) Vol. 7, pp. 100282-100282
Open Access
Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition
Xin Li, Yongcheng Song
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 18642-18655
Closed Access
Multi‐Targeted Antivirals
Bing Ye, Letian Song, Meehyein Kim, et al.
(2024), pp. 405-421
Closed Access
Validation of drug targets using molecular methodologies and enzymatic activity assays for validation of inhibitory potential
Sumaiya Khan, Saleha Anwar, Arunabh Choudhury, et al.
Elsevier eBooks (2024), pp. 91-112
Closed Access
Page 1

Scroll to top